Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

lenalidomide krka d.d. novo mesto (previously lenalidomide krka)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imunosupresoare - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

LENALIDOMIDA TEVA 5 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lenalidomida teva 5 mg

teva operations poland sp. z.o.o - polonia - lenalidomidum - caps. - 5mg - imunosupresoare alte imunosupresoare

ONDANSETRON KALCEKS 2 mg/ml Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ondansetron kalceks 2 mg/ml

akciju sabiedriba kalceks - letonia - ondansetronum - sol. inj./perf. - 2mg/ml - antiemetice antagonisti ai serotoninei (5ht-3)

Akeega Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

akeega

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - neoplasmele prostatice, rezistent la castrare - agenți antineoplazici - treatment of adult patients with prostate cancer.